Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-20

Clinical Trial Update: Safety and Efficacy of AL-53817 Nasal Spray Solution [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated the safety and efficacy of AL-53817 nasal spray for nasal allergies; results were completed and posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AL-53817 nasal spray solution (AL-53817)

Snippet

Sponsor: Alcon Research | Conditions: Nasal Allergies, Allergies | Phase 1 | Status: COMPLETED | Results posted: 2013-05-20